HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU REACH Analysis Corroborates Animal Welfare View: Testing Continues For Cosmetics-Only Ingredients

Executive Summary

A multi-stakeholder analysis of REACH data revealed that while animal testing of cosmetic ingredients dropped dramatically after March 2013 when the Cosmetic Products Regulation’s marketing ban on animal-tested ingredients was fully implemented, the practice did not cease altogether.

You may also be interested in...



‘We Need To Reckon With This’ – CIR Expert Panel On Extinction Of Animal Data

Donald Belsito, professor of dermatology at Columbia University Medical Center and one of the Cosmetic Ingredient Review Expert Panel’s two team leaders, says the group needs to adapt to the reality that new animal testing data for sensitization and other endpoints likely aren't coming.

ECHA: Registrants Using Skin Sensitization Alt Methods Should Update Dossiers Using OECD 497

The agency is aware of more than 14,000 substances on the EU market with some indication of skin-sensitization concern. Using the OECD guideline, adopted in June, registrants may be able to make conclusive predictions without use of animals and should update REACH dossiers accordingly.

Symrise Appealing REACH Animal Testing Mandates To EU High Court; Unilever, PETA To Intervene

The EU Court of Justice will consider whether the EU General Court erred in affirming ECHA decisions that require Symrise to conduct new animal testing to assess the reproductive and other health effects of UV filters homosalate and octisalate. In recent failed bids for interim relief, Symrise argued that the animal testing is likely to cause “irreparable damage” to its interests.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel